These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7529301)

  • 41. [Intravenous nimodipine in the treatment of cerebral vasospasm following subarachnoid hemorrhage caused by aneurysm rupture: a comparative multicenter study].
    Desbordes JM; Ades PE; Guggiari M
    Agressologie; 1989 Jun; 30(7):438-40. PubMed ID: 2683824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety evaluation on low-molecular-weight hydroxyethyl starch for volume expansion therapy in pediatric patients: a meta-analysis of randomized controlled trials.
    Li L; Li Y; Xu X; Xu B; Ren R; Liu Y; Zhang J; He B
    Crit Care; 2015 Mar; 19(1):79. PubMed ID: 25887704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm].
    Nishizawa Y
    Nihon Rinsho; 1993 Dec; 51 Suppl():389-96. PubMed ID: 8121018
    [No Abstract]   [Full Text] [Related]  

  • 44. Excessive use of hetastarch: An iatrogenic cause of bleeding and hypocalcemia?
    Haynes GR; Bailey MK
    Anesth Analg; 2000 Jun; 90(6):1455-6. PubMed ID: 10825341
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of hetastarch to albumin for perioperative bleeding in patients undergoing abdominal aortic aneurysm surgery. A prospective, randomized study.
    Gold MS; Russo J; Tissot M; Weinhouse G; Riles T
    Ann Surg; 1990 Apr; 211(4):482-5. PubMed ID: 1690974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Combination therapy (hypervolemia, Fluosol-DA 20%, hypertension) in the treatment of symptomatic vasospasm].
    Nagasawa S; Ohtsuki H; Yonekawa Y; Handa H
    No Shinkei Geka; 1986 Jan; 14(1):15-20. PubMed ID: 2419780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A severe coagulopathy following volume replacement with hydroxyethyl starch in a Jehovah's Witness.
    Lockwood DN; Bullen C; Machin SJ
    Anaesthesia; 1988 May; 43(5):391-3. PubMed ID: 2456703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of pentastarch on global cerebral ischemia and reperfusion.
    Haring HP
    Anesth Analg; 1995 Aug; 81(2):433-4. PubMed ID: 7542434
    [No Abstract]   [Full Text] [Related]  

  • 49. Hydroxyethyl starch--can the safety problems be ignored?
    Boldt J
    Wien Klin Wochenschr; 2004 Sep; 116(17-18):640-1. PubMed ID: 15515884
    [No Abstract]   [Full Text] [Related]  

  • 50. Severe coagulopathy in Jehovah's witness.
    Panchal HI; Ramwell J; Lawler PG
    Anaesthesia; 1989 Jan; 44(1):71-2. PubMed ID: 2467575
    [No Abstract]   [Full Text] [Related]  

  • 51. Plasma expanders and bleeding.
    Abramson N
    Ann Intern Med; 1988 Feb; 108(2):307. PubMed ID: 2449107
    [No Abstract]   [Full Text] [Related]  

  • 52. Pruritus after administration of hetastarch.
    Br Med J (Clin Res Ed); 1982 May; 284(6326):1405-6. PubMed ID: 6176288
    [No Abstract]   [Full Text] [Related]  

  • 53. Pruritus after administration of hetastarch.
    Parker NE; Porter JB; Williams HJ; Leftley N
    Br Med J (Clin Res Ed); 1982 Feb; 284(6313):385-6. PubMed ID: 6174172
    [No Abstract]   [Full Text] [Related]  

  • 54. Hetastarch Coagulopathy.
    Treib J; Haass A; Pindur G
    J Neurosurg; 1996 Aug; 85(2):367-8; author reply 368. PubMed ID: 8755778
    [No Abstract]   [Full Text] [Related]  

  • 55. Base excess determined within one hour of admission predicts mortality in patients with severe pelvic fractures and severe hemorrhagic shock.
    Abt R; Lustenberger T; Stover JF; Benninger E; Lenzlinger PM; Stocker R; Keel M
    Eur J Trauma Emerg Surg; 2009 Oct; 35(5):429. PubMed ID: 26815208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intra-operative hydroxyethyl starch is not associated with post-craniotomy hemorrhage.
    Feix JA; Peery CA; Gan TJ; Warner DS; James ML; Zomorodi A; McDonagh DL
    Springerplus; 2015; 4():350. PubMed ID: 26191477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Comparative Coagulopathic Study for Treatment of Vasospasm by Using Low- and High-molecular Weight Hydroxyethyl Starches.
    Hwang SH; Won YS; Yu JS; Yang JY; Choi CS
    J Korean Neurosurg Soc; 2007 Nov; 42(5):377-81. PubMed ID: 19096573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral Vasospasm Following Subarachnoid Hemorrhage.
    Topcuoglu MA; Pryor JC; Ogilvy CS; Kistler JP
    Curr Treat Options Cardiovasc Med; 2002 Oct; 4(5):373-384. PubMed ID: 12194810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coagulopathy with the use of hetastarch in the treatment of vasospasm.
    Trumble ER; Muizelaar JP; Myseros JS; Choi SC; Warren BB
    J Neurosurg; 1995 Jan; 82(1):44-7. PubMed ID: 7529301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of hetastarch with albumin for postoperative volume expansion in children after cardiopulmonary bypass.
    Brutocao D; Bratton SL; Thomas JR; Schrader PF; Coles PG; Lynn AM
    J Cardiothorac Vasc Anesth; 1996 Apr; 10(3):348-51. PubMed ID: 8725415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.